Zobrazeno 1 - 5
of 5
pro vyhledávání: '"G D Laverman"'
Autor:
A J Kwakernaak, L C Roksnoer, H J Lambers Heerspink, I van den Berg-Garrelds, G A Lochorn, J H van Embden Andres, M A Klijn, H Kobori, A H J Danser, G D Laverman, G J Navis
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169258 (2017)
The combination of weight excess and hypertension significantly contributes to cardiovascular risk and progressive kidney damage. An unfavorable renal hemodynamic profile is thought to contribute to this increased risk and may be ameliorated by direc
Externí odkaz:
https://doaj.org/article/4cde296d362742eabb0f1d2742bed54d
Autor:
C. M. Gant, M. M. Oosterwijk, S. H. Binnenmars, G. J. Navis, H. Haverkate, S. J. L. Bakker, G. D. Laverman
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Objective Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection and secondary prevention of cardiovascular disease in patients with type 2 diabetes. Althou
Externí odkaz:
https://doaj.org/article/fab4f68a8d0a4c43b9af7bda6a8448c5
Publikováno v:
The Netherlands journal of medicine. 68(12)
Before the introduction of renin-angiotensin-aldosterone system (RAAS) inhibitors in the 1980s, non-steroidal anti-inflammatory drugs (NSAIDs) were the only class of drugs available for the reduction of symptomatic proteinuria. Long-term data from th
Publikováno v:
The Netherlands journal of medicine. 68(11)
Autor:
M. C. J. Slagman, S. J. Sinkeler, M. H. Hemmelder, F. Waanders, L. Vogt, H. C. Kluin-Nelemans, G. Navis, G. D. Laverman
Publikováno v:
Nephrology Dialysis Transplantation. 25:2384-2384